Bromocriptine therapy: Review of mechanism of action, safety and tolerability-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bromocriptine therapy: Review of mechanism of action, safety and tolerability

Published:2022-06-22 Issue:8 Volume:49 Page:903-922
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharma Physio

Author:

Naz Faiza¹,Malik Abdul²,Riaz Muhammad³^ORCID,Mahmood Qaisar²⁴,Mehmood Malik Hassan⁵,Rasool Ghulam³,Mahmood Zahed⁶,Abbas Mazhar⁷

Affiliation:

1. Punjab University College of Pharmacy University of the Punjab Lahore Pakistan

2. College of Pharmacy University of Sargodha Sargodha Pakistan

3. Department of Allied Health Sciences University of Sargodha Sargodha Pakistan

4. Department of Pharmaceutical Sciences, Biomanufacturing Research Institute & Technology Enterprise North Carolina Central University Durham NC USA

5. Department of Pharmacology, Faculty of Pharmaceutical Sciences Government College University Faisalabad Pakistan

6. Department of Biochemistry Government College University Faisalabad Pakistan

7. Department of Biochemistry University of Veterinary and Animal Sciences Lahore (Jhang Campus) Lahore Pakistan

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13678

Reference390 articles.

1. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

2. Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes

3. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

4. Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

5. Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing erythrosine B absorption spectrum shifts for quantitative determination of octreotide and bromocriptine in their pure forms and pharmaceutical formulations. Evaluation of the method greenness;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2025-01

2. The Protective Effects of Acetyl L-Carnitine for The Offspring and Lactating Moms of Rats Received Bromocriptine;Egyptian Journal of Veterinary Sciences;2024-12-01

3. Marked Point Process Secretory Events Statistically Characterize Leptin Pulsatile Dynamics;Journal of the Endocrine Society;2024-08-27

4. Bromocriptine in the Management of Central Hyperthermia;EMJ Neurology;2024-08-13

5. Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity;Molecular Neurobiology;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3